request Request a Protocol
ask Ask a question
Favorite

The full-length SKP2 3′ UTR was PCR-amplified from human genomic DNA using the primers listed in SI Appendix, Table S7. This product was cloned into the psiCHECK-2 vector (Promega) using NotI and XhoI restriction sites and verified by Sanger sequencing. The miR-127 7mer-m8 target site in the WT SKP2 3′ UTR GGATCCG was substituted with CCGTGGC in the mutant SKP2 3′ UTR using QuikChange Lightening Site-Directed Mutagenesis Kit (Agilent) and the mutagenic primers listed in SI Appendix, Table S7. Sanger sequencing confirmed successful mutagenesis of the miR-127 7mer-m8 target site. psiCHECK-2 vector (Promega) containing either a WT or mutant 3′ UTR of SKP2 was cotransfected into LTC cells with 50 nM of miR-127 or NC mimic (Invitrogen) using the Lipofectamine 3000 Transfection Reagent (Invitrogen). The Renilla and firefly luciferase activities were measured 72 h posttransfection using the Dual-Luciferase Reporter System (Promega) following the manufacturer’s instructions. Renilla signals were normalized to an internal firefly luciferase as an internal control for transfection efficiency.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A